Table 1. Baseline patient characteristics.
| Group | Xenon (n = 93) | Sevoflurane (n = 94) |
|---|---|---|
| Age [yrs] | 48.0 ± 14.8 | 49.3 ± 14.1 |
| Height [m] | 1.72 ± 0.1 | 1.70 ± 0.1 |
| BMI [kg m-2] | 26.2 ± 4.8 | 25.1 ± 4.7 |
| Sex m/f [n] (%) | 39/54 (42/58) | 31/63 (33/67) |
| ASA I/II/III [n] (%) | 46/46/1 (49.5/49.5/1) | 43/50/1 (46/53/1) |
| History of PONV y/n [n] (%) | 10/83 (11/89) | 12/82 (13/87) |
| Apfel Score 2/3/4 [n] (median) | 54/33/6 (2) | 56/32/6 (2) |
A demographic baseline description of the subjects randomized for xenon or sevoflurane anesthesia are presented in Table 1. Age, height, and body mass index (BMI) are given as mean ± SD. Gender (m male/f female), ASA classification and history of PONV (y yes/n no) are shown in numbers and percent of total. The individual Apfel score is given in numbers by scoring and group median.